Myelodysplastic Syndrome Clinical Trial

Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry

Summary

This study is a collection of data to evaluate safety and characterize progression of Paroxysmal Nocturnal Hemoglobinuria (PNH).

View Full Description

Full Description

Collection of data to evaluate safety and characterize progression of Paroxysmal Nocturnal Hemoglobinuria (PNH).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients of any age, including minors, with a diagnosis of PNH or a detected PNH clone, including patients previously treated with Soliris or Ultomiris and withdrawn from treatment. Patients who are minors must have parent/legal guardian consent and must be willing and able to give assent, if applicable as determined by the Ethics Committees/Institutional Review Boards. Upon attaining adulthood, these patients must be re-consented.
Ability to comprehend and sign consent to have data entered in the PNH Registry.

Exclusion Criteria:

Inability or unwillingness to sign informed consent.
Patients currently enrolled in an interventional clinical trial for treatment of PNH cannot be enrolled in the Registry at the same time.

Study is for people with:

Myelodysplastic Syndrome

Estimated Enrollment:

5950

Study ID:

NCT01374360

Recruitment Status:

Recruiting

Sponsor:

Alexion Pharmaceuticals, Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Contact the PNH Registry at Alexion Pharmaceuticals, Inc. for worldwide locations.
Boston Massachusetts, 02210, United States More Info
PNH Registry
Contact

How clear is this clinincal trial information?

Study is for people with:

Myelodysplastic Syndrome

Estimated Enrollment:

5950

Study ID:

NCT01374360

Recruitment Status:

Recruiting

Sponsor:


Alexion Pharmaceuticals, Inc.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.